Literature DB >> 30234521

Influences of COMT rs4680 and OPRM1 rs1799971 Polymorphisms on Chronic Postsurgical Pain, Acute Pain, and Analgesic Consumption After Elective Cesarean Delivery.

Lizhong Wang1, Changna Wei, Fe Xiao, Xiangyang Chang, Yinfa Zhang.   

Abstract

OBJECTIVES: The main objectives of this study were to assess the effects of cathechol-O-methyl-transferase (COMT) rs4680 and μ-opioid receptor rs1799971 polymorphisms alone or genotype combinations on chronic postsurgical pain (CPSP), acute pain, and analgesic consumption after elective cesarean delivery in a Chinese cohort.
MATERIALS AND METHODS: Two hundred sixty-six patients undergoing elective cesarean delivery with a Pfannenstiel incision under spinal anesthesia were enrolled in this prospective, observational study. All patients were screened for rs4680 and rs1799971 using a peripheral venous blood sample of DNA. Postoperative pain relief was provided by IV patient-controlled analgesia with sufentanyl and tramadol for 48 hours postoperatively. Postoperative pain scores and analgesic consumption were assessed, and CPSP was evaluated 3 months after surgery in all patients.
RESULTS: Twenty-nine patients (29/266; 10.9%) developed CPSP at 3 months after surgery. The risk factors for CPSP included previous cesarean delivery and higher analgesic consumptions at 24 hours and 48 hours postoperatively (P=0.032, 0.015, and 0.008, reapectively). No associations were found between CPSP and a single rs4680 and rs1799971 polymorphism, or their combinations (P>0.05). In contrast, patients with rs1799971 GG required higher patient-controlled analgesics at 24 hours and 48 hours postoperatively compared with those with other genotypes (GG>AG>AA). However, no significant effects of interactions between the 2 single nucleotide polymorphisms on analgesic consumption were observed. DISCUSSION: Our results indicate that cathechol-O-methyl-transferase rs4860 and μ-opioid receptor rs1799971 may not contribute to CPSP development after cesarean delivery. The genotype of rs1799971 affects postcesarean analgesic requirement, while the rs4680 do not. Additional larger studies are needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30234521     DOI: 10.1097/AJP.0000000000000654

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  5 in total

Review 1.  Persistent pain after childbirth.

Authors:  H S Tan; B L Sng
Journal:  BJA Educ       Date:  2021-11-08

2.  The Role of Pharmacogenomics in Postoperative Pain Management.

Authors:  E Paylor Sachtleben; Kelsey Rooney; Hannah Haddad; Victoria L Lassiegne; Megan Boudreaux; Elyse M Cornett; Alan D Kaye
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Genetic and epigenetic mechanisms influencing acute to chronic postsurgical pain transitions in pediatrics: Preclinical to clinical evidence.

Authors:  Adam J Dourson; Adam Willits; Namrata G R Raut; Leena Kader; Erin Young; Michael P Jankowski; Vidya Chidambaran
Journal:  Can J Pain       Date:  2022-05-10

Review 4.  Factors associated with persistent pain after childbirth: a narrative review.

Authors:  Ryu Komatsu; Kazuo Ando; Pamela D Flood
Journal:  Br J Anaesth       Date:  2020-01-17       Impact factor: 9.166

5.  COMT rs4818, pain sensitivity and duration, and alveolar bone grafting of oral clefts.

Authors:  E M V M Silva; R H W Lacerda; I L Farias; B G N Cavalcante; I O Assis; M Bezamat; A Modesto; Alexandre Rezende Vieira
Journal:  Oral Maxillofac Surg       Date:  2020-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.